On November 12, Hims & Hers Health Inc. fell 5.43% in Regular Trading, trading at $19.67 per share with turnover of $18.1774 million.
The move appears tied to continued selling pressure after the company reported third-quarter results below expectations and issued softer fourth-quarter and full-year revenue guidance, while the Federal Trade Commission amended its lawsuit to add five states as co-plaintiffs.
In the latest reported quarter, Hims & Hers Health Inc. posted a loss of $0.14 per share versus market expectations for a profit of $0.06, while revenue rose to $890.4 million but missed the $893.1 million consensus. The company guided fourth-quarter revenue to $875 million-$895 million, below the $953.8 million expected, and projected full-year revenue of $3.13 billion-$3.15 billion versus a $3.21 billion consensus. Separately, the expanded FTC case centers on allegations involving sensitive health information sharing, billing, and subscription cancellation practices, adding near-term uncertainty.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments